Cellect Biotechnology Ltd. (APOP)
| Market Cap | 13.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.10M |
| Shares Out | 980,434 |
| EPS (ttm) | -0.85 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 103,633 |
| Open | 14.00 |
| Previous Close | 14.44 |
| Day's Range | 13.01 - 14.00 |
| 52-Week Range | 6.60 - 35.52 |
| Beta | 1.88 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About APOP
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative d...
News
Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Q...
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs...
5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted s...
Why Cellect Biotechnology Shares Are Rising Today
Cellect Biotechnology Ltd (NASDAQ: APOP) is trading higher Monday after the company announced shareholder approval of the strategic merger with Quoin Pharmaceuticals. Approximately 99% of the votes were...
Here's why Cellect Biotechnology shares are up 50% on Monday
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of th...
Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held ...
See Why Cellect Biotechnology Stock Is Soaring During Premarket Friday
Cellect Biotechnology Ltd (NASDAQ: APOP) announced the first ApoGraft transplantation in a Leukemia patient in a clinical trial in the U.S. ApoGraft is designed to prevent graft-versus-host disease (GV...
Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.
Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity En...
Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter
The Securities and Exchange Commission Declared Cellect Biotechnology's Registration Statement Filed on Form F-4 Effe...
Special General Meeting of Shareholders Scheduled for September 19, 2021
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...
Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop
Short squeeze stocks have been targeted quite a bit lately as retail traders tackle them in an effort to push out hedge funds. The post Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think A...
These Penny Stocks Are Up Big Today, Worth It or Not?
3 big gaining penny stocks today; are they worth it? The post These Penny Stocks Are Up Big Today, Worth It or Not?
Why Are Cellect Biotechnology (APOP) Shares Surging Today?
Cellect Biotechnology Ltd (NASDAQ: APOP) has filed a registration statement with the SEC in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals Inc. See the SEC regis...
Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin ...
Transaction Expected to Close in the 2021 Third Quarter Transaction Expected to Close in the 2021 Third Quarter
Are These Penny Stocks The Biggest Morning Movers?
These penny stocks moved in early morning trading; will you add them to your watchlist? The post Are These Penny Stocks The Biggest Morning Movers?
5 Hot Penny Stocks To Buy? Check These Out For May 2021
Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?
Market Update: The 10 Most Volatile Stocks Today
Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on In...
Cellect Bio's ApoGraft Therapy Is Safe, Tolerable In GvHD Study
Cellect Biotechnology Ltd (NASDAQ: APOP) has announced data from the Phase 1/2 study in Israel evaluating ApoGraft technology for Graft versus Host Disease (GvHD), a severe complication of allogeneic he...
Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
TEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today reported...
Why Cellect, Immutep, F-star, ProQR and Evofem Are Moving Thursday
Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.
Why PRQR Stock And APOP Stock Are Popping Off Today
ProQR Therapeutics NV (NASDAQ: PRQR) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge i...
APOP Stock: Why Cellect Biotechnology Is Skyrocketing Today
APOP stock holders are getting a 1:3 ratio of shares in the tie-up deal. The merger brings together Cellect's stem cell tech with Quoin's rare and orphan diseases focus.
Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic Merger
Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger
Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to ...
Promising Progress on Clinical D evelopment Progress , Collaboration s and Partnering